Chemotherapy is associated with cognitive impairment in a subgroup of breast cancer
survivors, but the neural circuitry underlying this side effect is largely unknown. Moreover, long‐…

The neural substrate underlying cognitive impairments after chemotherapy is largely unknown.
Here, we investigated very late (>9 years) effects of adjuvant high‐dose chemotherapy …

Objective: Neuroimaging studies show structural alterations of various brain regions in children
and adults with attention deficit hyperactivity disorder (ADHD), although nonreplications …

Dopamine transporter imaging is a valuable tool to investigate the integrity of the dopaminergic
neurons. To date, several reports have shown an age-associated decline in dopamine …

Background 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) is a popular recreational
drug that has been shown to damage brain serotonin neurons in high doses. However, …

Background Although the popular drug 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy")
has been shown to damage brain serotonin (5-HT) neurons in animals, the fate and …

Major depressive disorder (MDD) is associated with an increased risk of brain atrophy,
aging-related diseases, and mortality. We examined potential advanced brain aging in adult …

Rationale: Methylenedioxymethamphetamine (MDMA) is known to damage brain pre-synaptic
serotonin (5-HT) neurons. Since loss of 5-HT neurons has been implicated in memory loss…

PURPOSE: To determine whether childhood medulloblastoma and acute lymphoblastic
leukemia (ALL) survivors have decreased white matter fractional anisotropy (WMFA) and …

A key objective in the field of translational psychiatry over the past few decades has been to
identify the brain correlates of major depressive disorder (MDD). Identifying measurable …